Literature DB >> 8592062

Elevated levels of the endogenous retrovirus ERV3 in human sebaceous glands.

A C Andersson1, M Merza, P Venables, F Pontén, J Sundström, M Cohen, E Larsson.   

Abstract

ERV3 (HERV-R) is a complete human endogenous retrovirus located on the long arm of chromosome 7. Long terminal repeat-envelope (env) gene spliced mRNAs of 9 and 3.5 kb are widely expressed in human tissues and cells, but gag-pol mRNAs have not been found. Furthermore, the env gp70 gene contains an open reading frame throughout its length. The highest expression of ERV3 mRNA detected so far is in placenta and the lowest in choriocarcinoma cell lines. We have previously shown that the human monoblastic cell line U-937 and some normal and neoplastic tissues also express high levels of ERV3 env message by Northern blot analysis; however, this method does not distinguish between mRNA expression in different cell types in tissues. In this report, we have studied the ERV3 mRNA expression in specific cell types of human skin by in situ hybridization. We found high levels expression of ERV3 env mRNA in human sebaceous glands in normal skin and dermoid cysts of the ovary. In all glands, the expression is maximal in the periphery of the lobule and ceases towards the center in the region of characteristic holocrine secretion. Since it is known that the regulation of sebaceous glands is primarily via steroid hormones, particularly androgens, it is possible that expression of ERV3 is hormone dependent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8592062     DOI: 10.1111/1523-1747.ep12329612

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

Review 1.  An alternative approach to medical genetics based on modern evolutionary biology. Part 2: retroviral symbiosis.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2009-08       Impact factor: 5.344

2.  Physiological knockout of the envelope gene of the single-copy ERV-3 human endogenous retrovirus in a fraction of the Caucasian population.

Authors:  N de Parseval; T Heidmann
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

3.  ERV3 and related sequences in humans: structure and RNA expression.

Authors:  Ann-Catrin Andersson; Zhihong Yun; Göran O Sperber; Erik Larsson; Jonas Blomberg
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Tissue specific high level expression of a full length human endogenous retrovirus genome transgene, HERV-R, under control of its own promoter in rats.

Authors:  Satoshi Tanaka; Hitoshi Ikeda; Noriyuki Otsuka; Yukiyo Yamamoto; Toshiaki Sugaya; Takashi Yoshiki
Journal:  Transgenic Res       Date:  2003-06       Impact factor: 2.788

Review 5.  Human endogenous retroviruses in health and disease: a symbiotic perspective.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2004-12       Impact factor: 18.000

6.  Human endogenous retrovirus W activity in cartilage of osteoarthritis patients.

Authors:  Signy Bendiksen; Inigo Martinez-Zubiavrra; Conny Tümmler; Gunnar Knutsen; Jan Elvenes; Elisabeth Olsen; Randi Olsen; Ugo Moens
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

7.  Expression of selected human endogenous retroviral sequences in skin and peripheral blood mononuclear cells in morphea.

Authors:  Michał J Kowalczyk; Aleksandra Dańczak-Pazdrowska; Beata Szramka-Pawlak; Ryszard Zaba; Wojciech Silny; Agnieszka Osmola-Mańkowska
Journal:  Arch Med Sci       Date:  2012-10-08       Impact factor: 3.318

Review 8.  Endogenous Retrovirus 3 - History, Physiology, and Pathology.

Authors:  Yomara Y Bustamante Rivera; Christine Brütting; Caroline Schmidt; Ines Volkmer; Martin S Staege
Journal:  Front Microbiol       Date:  2018-01-15       Impact factor: 5.640

Review 9.  Retroviruses of the Human Virobiota: The Recycling of Viral Genes and the Resulting Advantages for Human Hosts During Evolution.

Authors:  Anna Luganini; Giorgio Gribaudo
Journal:  Front Microbiol       Date:  2020-05-28       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.